Nancy Writebol, an American aid worker from North Carolina who was infected with the Ebola virus while working in Liberia, arrives at Emory University Hospital in Atlanta, Tuesday, Aug. 5, 2014. Writebol is expected to be admitted to the hospital, where she will join another U.S. aid worker, Dr. Kent Brantly, in a special isolation unit. (AP Photo/(AP Photo/The Journal & Constitution, John Spink)
Nancy Writebol, an American aid worker from North Carolina who was infected with the Ebola virus while working in Liberia, arrives at Emory University Hospital in Atlanta, Tuesday, Aug. 5, 2014. Writebol is expected to be admitted to the hospital, where she will join another U.S. aid worker, Dr. Kent Brantly, in a special isolation unit. (AP Photo/The Journal & Constitution, John Spink)

(The Washington Post) – As the death toll from the Ebola virus in four West African nations topped 1,000, an official from the World Health Organization said she hopes accelerated efforts to develop treatments might yield more medicine by the end of this year.

Marie-Paule Kieny, assistant WHO director general, said she hopes that work to produce more of the medication developed by a small San Diego biopharmaceutical company, as well as other drugs, could result in wider availability sometime late in 2014 — perhaps between November and January of 2015.

WHO said Tuesday that the death toll in Guinea, Sierra Leone, Liberia and Nigeria had reached 1,013. A small number of doses of an experimental treatment — perhaps 1o total, Kieny said — were exhausted with their distribution to Liberia on Monday for the treatment of two doctors there who have been stricken by the virus, according to Mapp Biopharmaceutical, which developed the drug.

READ MORE

Leave a comment

Your email address will not be published. Required fields are marked *

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, https://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact